{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:57:02Z","timestamp":1774382222138,"version":"3.50.1"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2019,4,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Pyrimidines emerged as a remarkable class of heterocyclic compounds\nthat have reinforced the pharmaceutical chemistry with various bioactive antitumor agents.\nMoreover, pyrimidine scaffold displayed VEGFR-2 inhibitory activity. Also, nano-sized catalysts\nare used in organic reactions in order to speed up the catalytic process.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> We were interested herein to synthesize a new series of fused pyrimidines using\nZnO(NPs) to investigate their antitumor efficiency against breast MCF7 cancer and their VEGFR-\n2 inhibition properties.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p> A simple and efficient method for the synthesis of fused pyrimidines was developed using\nzinc oxide nanoparticles ZnO(NPs) in refluxing ethanol.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> The proposed structures of all new fused pyrimidines are in agreement with their spectral\ndata. Antitumor evaluation of newly fused pyrimidine derivatives against breast MCF-7 cancer\nwas performed. It was apparent that the 2-phenylpyrazolo[1,5-a]pyrimidine derivatives 9a (IC50 =\n9.12\u00b11.16 \u00b5g\/ml), 9c (IC50 = 9.10\u00b11.07 \u00b5g\/ml) and 9d (IC50 = 9.60\u00b11.22 &amp;\u00b5g\/ml) exhibited equipotent\nantitumor activity as Tamoxifen (IC50 = 9.11\u00b10.90 &amp;\u00b5g\/ml). Also, the inhibitory activity of\nthe novel fused pyrimidine derivatives on VEGFR-2 as well as Tamoxifen was determined using\nbreast cancer cell line MCF-7. The data was obvious that 2-phenylpyrazolo[1,5-a]pyrimidine derivatives\n9a, 9c and 9d exhibited noticeable VEGFR-2 inhibitory effect with % inhibition ranging\nfrom 80-84 % versus Tamoxifen 93.5%.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> We succeeded in this context to synthesize new fused pyrimidines using ZnO(NPs)\nas anti-breast cancer agents targeting VEGFR-2.&lt;p&amp;gt;<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406414666180912113226","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T08:06:28Z","timestamp":1536739588000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["ZnO Nanoparticles Catalyst in the Synthesis of Bioactive Fused Pyrimidines as Anti-breast Cancer Agents Targeting VEGFR-2"],"prefix":"10.2174","volume":"15","author":[{"given":"Dina H.","family":"Dawood","sequence":"first","affiliation":[{"name":"Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Division, National Research Center, 33 El Bohouth St.( former El Tahrir St.) Dokki, Giza, P.O. Box 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman M.H.","family":"Abbas","sequence":"additional","affiliation":[{"name":"Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Division, National Research Center, 33 El Bohouth St.( former El Tahrir St.) Dokki, Giza, P.O. Box 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thoraya A.","family":"Farghaly","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamdouh M.","family":"Ali","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Genetic Engineering and Biotechnology Research Division, National Research Center, 33 El Bohouth St. (former El Tahrir St.) Dokki, Giza, P.O. Box 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed F.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Genetic Engineering and Biotechnology Research Division, National Research Center, 33 El Bohouth St. (former El Tahrir St.) Dokki, Giza, P.O. Box 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molonc.2012.02.004","volume":"6","author":"Hoelder S.","year":"2012","unstructured":"Hoelder S, Clarke PA, Workman P.  Discovery of small molecule cancer drugs: Successes, challenges and opportunities.","journal-title":"Mol Oncol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/jm001104n","volume":"44","author":"Hutchinson I.","year":"2001","unstructured":"Hutchinson I, Chua MS, Browne HL, Trapani V, Bradshaw TD, Westwell AD, Stevens MFG.  Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl) benzothiazoles.","journal-title":"J Med Chem"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/jcb.24589","volume":"114","author":"Callero M.A.","year":"2013","unstructured":"Callero MA, Luzzani GA, De Dios DO, Bradshaw TD, Perez AIL.  Biomarkers of sensitivity to potent and selective antitumor 2-(4-amino-3-methylphenyl)-5-fluoro benzothiazole (5F203) in ovarian cancer.","journal-title":"J Cell Biochem"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/jm050942k","volume":"49","author":"Mortimer C.G.","year":"2006","unstructured":"Mortimer CG, Wells G, Crochard JP, Stone EL, Bradshaw TD, Steven MFG, Westwel AD.  Antitumor benzothiazoles. 26.1 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selec-tive inhibitory activity against lung, colon and breast cancer cell lines.","journal-title":"J Med Chem"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14756360802205398","volume":"23","author":"Kadri H.","year":"2008","unstructured":"Kadri H, Matthews CS, Bradshaw TD, Stevens MFG, Westwell AD.  Synthesis and antitumour evaluation of novel 2-phenylbenzimidazoles.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1021\/acs.analchem.6b05115","volume":"89","author":"Wu L.","year":"2017","unstructured":"Wu L, Yang SH, Xiong H, Yang JQ, Guo J, Yang WC, Yang GF.  Nonpeptide-based small-molecule probe for fluorogenic and chromogenic detection of chymotrypsin.","journal-title":"Anal Chem"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.bmc.2016.05.018","volume":"24","author":"Siddiqui H.","year":"2016","unstructured":"Siddiqui H, Farooq R, Marasini BP, Malik R, Syed N, Moin ST, Rahman A, Choudhary MI.  Synthesis and in vitro \u03b1-chymotrypsin inhibitory activity of 6-chlorobenzimidazole derivatives.","journal-title":"Bioorg Med Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jhet.5570020424","volume":"2","author":"Ridley H.F.","year":"1965","unstructured":"Ridley HF, Spickett RGW, Timmis GM.  A new synthesis of benzimidazoles and aza-analogs.","journal-title":"J Heterocycl Chem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1515\/znc-2012-9-1007","volume":"67","author":"G\u00f6ker H.","year":"2012","unstructured":"G\u00f6ker H, Karaaslan C, Yildiz S.  Potent antifungal and antistaphylococcal 2-anilinobenzimidazoles.","journal-title":"Z Naturforsch C"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ejmech.2005.05.002","volume":"40","author":"G\u00f6ker H.","year":"2005","unstructured":"G\u00f6ker H, Ozden S, Yildiz S, Boykin D.  Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines.","journal-title":"Eur J Med Chem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/10111377","volume":"10","author":"G\u00f6ker H.","year":"2005","unstructured":"G\u00f6ker H, Alp M, Yild\u0131z S.  Synthesis and potent antimicrobial activity of some novel N-(alkyl)-2-phenyl-1H-benzimidazole-5-carboxamidines.","journal-title":"Molecules"},{"key":"ref=12","author":"Cavalla D.J.","year":"1996","unstructured":"Cavalla DJ, Chasin M, Hofer P, Dolby L.","journal-title":"Novel benzoxazoles"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.bmcl.2011.02.064","volume":"21","author":"Ha Y.M.","year":"2011","unstructured":"Ha YM, Park JY, Park YJ, Park D, Choi YJ, Kim JM, Lee EK, Han YK, Kim JA, Lee JY, Moon HR, Chung HY.  Syn-thesis and biological activity of hydroxy substituted phenyl- benzo[d]thiazole analogues for antityrosinase activity in B16 cells.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1021\/jm00383a006","volume":"24","author":"Robertson D.W.","year":"1985","unstructured":"Robertson DW, Beedle EE, Krushinski JH, Pollock GD, Wilson H, Wyss VL, Hayes JS.  Structure-activity relationships of arylimidazopyridine cardiotonics: Discovery and inotropic activity of 2-[-Methoxy-4-(methylsulfiny1) phenyl-1H-imidazo [,5-c] pyri-dine.","journal-title":"J Med Chem"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s00044-017-1806-0","volume":"26","author":"Taha M.","year":"2017","unstructured":"Taha M, Ismail NH, Imran S, Ainaa I, Selvaraj M, Baharudin MS, Ali M, Khan KM, Uddin N.  Synthesis of 2-phenyl-1H-imidazo [,5-b] pyridine as type 2 diabetes inhibitors and molecular docking studies.","journal-title":"Med Chem Res"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jhet.5570450542","volume":"45","author":"Das B.","year":"2008","unstructured":"Das B, Kanth BS, Reddy KR, Kumar AS.  Sulfonic acid functionalized silica as an efficient heterogeneous recyclable catalyst for one-pot synthesis of 2-substituted benzimidazoles.","journal-title":"J Heterocycl Chem"},{"key":"ref=17","first-page":"1296","volume":"2","author":"Gurudatt D.M.","year":"2013","unstructured":"Gurudatt DM, Mohana KN.  Synthesis of new benzimidazole derivatives and their corrosion inhibition performance on mild steel in 0.5 M hydrochloric acid.","journal-title":"J Applicab Chem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ardp.200700088","volume":"340","author":"Kilcigil G.","year":"2007","unstructured":"Kilcigil G, Kus C, Ozdamar ED, Eke B, Iscan M.  Synthesis and antioxidant capacities of some new benzimidazole derivatives.","journal-title":"Arch Pharm"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bioorg.2015.05.010","volume":"61","author":"Taha M.","year":"2015","unstructured":"Taha M, Ismail NH, Imran S, Selvaraj M, Rashwan H, Farhanah FU, Rahim F, Kesavanarayanan KS, Ali M.  Synthesis of benzimidazole derivatives as potent B-glucuronidase inhibitors.","journal-title":"Bioorg Chem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1080\/00397910701473325","volume":"37","author":"Navarrete-V\u00e1zquez G.","year":"2007","unstructured":"Navarrete-V\u00e1zquez G, Moreno-Diaz H, Estrada-Soto S, Torres-Piedra M.  Microwave-assisted one-pot synthesis of 2-(substitutedphenyl)-1H-benzimidazole derivatives.","journal-title":"Synth Commun"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1521-4184(200105)334:5<148::AID-ARDP148>3.0.CO;2-S","volume":"334","author":"G\u00f6ker H.","year":"2001","unstructured":"G\u00f6ker H, Tuncbilek M, Suzen S, Kus C, Altanlar N.  Synthesis and antimicrobial activity of some new 2-Phenyl-N-substituted car-boxamido-1H-benzimidazole derivatives.","journal-title":"Arch Pharm Pharm Med Chem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1016\/j.tetlet.2008.08.041","volume":"49","author":"Mukhopadhyay C.","year":"2008","unstructured":"Mukhopadhyay C, Tapaswi PK.  PEG-mediated catalyst-free expeditious synthesis of 2-substituted benzimidazoles and bis-benzimidazoles under solvent-less conditions.","journal-title":"Tetrahedron Lett"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.","journal-title":"J Immunol Methods"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fitote.2012.03.006","volume":"83","author":"Ku\u017ama L.","year":"2012","unstructured":"Ku\u017ama L, Wysoki\u0144ska H, R\u00f3\u017calski M, Krajewska U, Kisiel W.  An unusual taxodione derivative from hairy roots of Salvia austriaca.","journal-title":"Fitoterapia"},{"key":"ref=25","author":"","year":"2015","unstructured":"Clinical and Laboratory Standard Institute (CLSI). Methods for\nDilution Antimicrobial Susceptibility Tests for Bacteria That Grow\nAerobically; Approved Standard\u2014Ninth Edition M07-A9, Vol. 32,\nNo. 2, 2015."},{"key":"ref=26","author":"","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Reference\nmethod for broth dilution antifungal susceptibility testing of yeasts.\n3rd ed.; M27-A3, Wayne, PA: CLSI, 2008."}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T15:05:13Z","timestamp":1563548713000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165344\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406414666180912113226","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-02-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}